What does the Institutional Biosafety Committee Review?
Experiments that require IBC approval include those that involve: • the deliberate transfer of a drug resistance trait to microorganisms that are not known to acquire the trait naturally, • the deliberate transfer of recombinant DNA or DNA or RNA derived from recombinant DNA into human research participants [human gene transfer], • the deliberate formation of recombinant DNA containing genes for the biosynthesis of toxin molecules lethal for vertebrates at an LD50 of less than 100 micrograms per kilogram body weight, • using risk group 2 or risk group 3 agents as host-vector systems, • the cloning of DNA from risk group 2 or risk group 3 agents into non-pathogenic prokaryotes or lower eukaryotic host-vector systems, • the use of infectious or defective risk group 2 or risk group 3 agents, • whole animals in which the animal’s genome has been altered by stable introduction of recombinant DNA or DNA derived into the germ-line [transgenic animal], • viable recombinant DNA-modified microor
Related Questions
- Will time requirements for documentation submitted to the Institutional Review Board (IRB)/ Ethics Committee (EC) also apply for consents that must be translated into other languages as well?
- Do StudentVoice assessment projects go through the Institutional Review Board (IRB)/Human Subjects Review Committee process?
- What type of research activities does the Institutional Biosafety Committee (IBC) review?
